effector.comHealthcareFounded: 2012Funding to Date: $152.08MM
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).
View Enterprise Value for eFFECTOR Therapeutics.